NUCLEIC ACID OF ANTIGEN AND HEPATITIS B VIRUS (HBV) - ANVISA Registration 80020690429
Access comprehensive regulatory information for NUCLEIC ACID OF ANTIGEN AND HEPATITIS B VIRUS (HBV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80020690429 and manufactured by manufacturer not specified. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until Aug 05, 2034.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including programa nacional de controle de qualidade ltda, and 1 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
80020690429
25351660240202311
03188198000177
Company Information
Dates and Status
Aug 05, 2024
05/08/2034
09/18/2025 19:00:01
NUCLEIC ACID OF ANTIGEN AND HEPATITIS B VIRUS (HBV)
Família Biologia Molecular HBV Controle Interno
programa nacional de controle de qualidade ltda
80155020042
Dec 18, 2023
HEPATITIS C VIRUS NUCLEIC ACID (HCV)
Família HCV Run Control
Not specified
80020690433
Oct 21, 2024
HEPATITIS C VIRUS NUCLEIC ACID (HCV)
Família HCV Run Control
EXACT DIAGNOSTICS
80020690433
Oct 21, 2024
NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1)
Família HIV Run Control
EXACT DIAGNOSTICS
80020690434
Oct 21, 2024
NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1)
Família HIV Run Control
Not specified
80020690434
Oct 21, 2024